Royal Bank of Canada’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-75,500
Closed -$20.6M 7186
2025
Q4
$20.6M Buy
75,500
+15,500
+26% +$4.21M ﹤0.01% 1485
2025
Q3
$16.2M Buy
+60,000
New +$16.3M ﹤0.01% 1814
2025
Q1
Sell
-100,000
Closed -$23.2M 6864
2024
Q4
$23.2M Buy
+100,000
New +$23M ﹤0.01% 1258
2024
Q2
Sell
-4,900
Closed -$1.05M 7106
2024
Q1
$1.05M Buy
+4,900
New +$1.03M ﹤0.01% 3423
2019
Q2
Sell
-1,700
Closed -$280K 6897
2019
Q1
$280K Buy
1,700
+1,300
+325% +$230K ﹤0.01% 4142
2018
Q4
$75K Buy
+400
New +$73.9K ﹤0.01% 4877

Other funds holding CME

Royal Bank of Canada's CME Position: Q1 2026 in Review

Royal Bank of Canada reduced its CME Group (CME) stake by 10% in Q1 2026, selling an estimated $97.7M and leaving 2,950,082 shares worth $871M. The position accounts for 0.15% of the portfolio, ranked #131.

Royal Bank of Canada first reported a position in CME in Q2 2013 and has held it in 52 quarters since. The position peaked at $939M in Q2 2025. 1,796 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Royal Bank of Canada held 2,950,082 shares of CME Group worth $871M as of Q1 2026.
  • Royal Bank of Canada sold 328,873 CME Group shares in Q1 2026, an estimated $97.7M.
  • CME Group made up 0.15% of Royal Bank of Canada's portfolio in Q1 2026, its #131 holding.
  • Royal Bank of Canada first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's CME Group position peaked at $939M in Q2 2025.
  • 1,796 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.